These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15948030)

  • 1. Formulating paclitaxel in nanoparticles alters its disposition.
    Yeh TK; Lu Z; Wientjes MG; Au JL
    Pharm Res; 2005 Jun; 22(6):867-74. PubMed ID: 15948030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice.
    Ho PY; Yeh TK; Yao HT; Lin HL; Wu HY; Lo YK; Chang YW; Chiang TH; Wu SH; Chao YS; Chen CT
    Int J Pharm; 2008 Jul; 359(1-2):174-81. PubMed ID: 18513900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy.
    Lu Z; Yeh TK; Tsai M; Au JL; Wientjes MG
    Clin Cancer Res; 2004 Nov; 10(22):7677-84. PubMed ID: 15570001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel.
    Tsai M; Lu Z; Wang J; Yeh TK; Wientjes MG; Au JL
    Pharm Res; 2007 Sep; 24(9):1691-701. PubMed ID: 17447121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?
    Li C; Li Y; Gao Y; Wei N; Zhao X; Wang C; Li Y; Xiu X; Cui J
    Int J Pharm; 2014 Jul; 468(1-2):15-25. PubMed ID: 24709221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
    Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ
    Cancer Chemother Pharmacol; 2009 May; 63(6):1049-63. PubMed ID: 18791718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles.
    Dhanikula AB; Singh DR; Panchagnula R
    Curr Drug Deliv; 2005 Jan; 2(1):35-44. PubMed ID: 16305406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of paclitaxel-containing liposomes in rats.
    Fetterly GJ; Straubinger RM
    AAPS PharmSci; 2003 Nov; 5(4):E32. PubMed ID: 15198520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.
    Sparreboom A; van Tellingen O; Nooijen WJ; Beijnen JH
    Cancer Res; 1996 May; 56(9):2112-5. PubMed ID: 8616858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes.
    Crosasso P; Ceruti M; Brusa P; Arpicco S; Dosio F; Cattel L
    J Control Release; 2000 Jan; 63(1-2):19-30. PubMed ID: 10640577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).
    Sparreboom A; Scripture CD; Trieu V; Williams PJ; De T; Yang A; Beals B; Figg WD; Hawkins M; Desai N
    Clin Cancer Res; 2005 Jun; 11(11):4136-43. PubMed ID: 15930349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
    Gill KK; Nazzal S; Kaddoumi A
    Eur J Pharm Biopharm; 2011 Oct; 79(2):276-84. PubMed ID: 21575719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor.
    Li C; Newman RA; Wu QP; Ke S; Chen W; Hutto T; Kan Z; Brannan MD; Charnsangavej C; Wallace S
    Cancer Chemother Pharmacol; 2000; 46(5):416-22. PubMed ID: 11127947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
    Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
    J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy.
    Ruttala HB; Ko YT
    Pharm Res; 2015 Mar; 32(3):1002-16. PubMed ID: 25213777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration.
    Li R; Eun JS; Lee MK
    Arch Pharm Res; 2011 Feb; 34(2):331-7. PubMed ID: 21380818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment.
    Knemeyer I; Wientjes MG; Au JL
    Cancer Chemother Pharmacol; 1999; 44(3):241-8. PubMed ID: 10453726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with pluronic P105/poly(caprolactone) copolymers.
    Wang Y; Li Y; Wang Q; Fang X
    Pharmazie; 2008 Jun; 63(6):446-52. PubMed ID: 18604988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
    Wang X; Deng L; Chen X; Pei H; Cai L; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Mar; 100(3):1196-205. PubMed ID: 20860011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.